144 related articles for article (PubMed ID: 10435781)
1. Effects of mu and kappa opioid receptor antagonists on glucoprivic induction of Fos immunoreactivity in the rat preoptic area and hypothalamus.
Briski KP; Teodecki L
Brain Res Bull; 1999 Jun; 49(3):181-7. PubMed ID: 10435781
[TBL] [Abstract][Full Text] [Related]
2. Co-distribution of Fos- and mu opioid receptor immunoreactivity within the rat septopreoptic area and hypothalamus during acute glucose deprivation: effects of the mu receptor antagonist CTOP.
Briski KP; Sylvester PW
Neurosci Lett; 2001 Jun; 306(3):141-4. PubMed ID: 11406315
[TBL] [Abstract][Full Text] [Related]
3. Site-specific induction of Fos immunoreactivity in preoptic and hypothalamic NADPH-positive neurons during glucoprivation.
Briski KP; Sylvester PW
Neuroendocrinology; 1999 Mar; 69(3):181-90. PubMed ID: 10087450
[TBL] [Abstract][Full Text] [Related]
4. Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats.
Koch JE; Glass MJ; Cooper ML; Bodnar RJ
Neuroscience; 1995 Jun; 66(4):951-7. PubMed ID: 7651622
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala.
Carr KD; Kutchukhidze N; Park TH
Brain Res; 1999 Mar; 822(1-2):34-42. PubMed ID: 10082881
[TBL] [Abstract][Full Text] [Related]
6. Induction of immediate-early gene expression in preoptic and hypothalamic neurons by the glucocorticoid receptor agonist, dexamethasone.
Briski KP; DiPasquale BM; Gillen E
Brain Res; 1997 Sep; 768(1-2):185-96. PubMed ID: 9369315
[TBL] [Abstract][Full Text] [Related]
7. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
Rivest S; Plotsky PM; Rivier C
Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
[TBL] [Abstract][Full Text] [Related]
8. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous opiates in glucoprivic inhibition of the luteinizing hormone surge and fos expression by preoptic gonadotropin-releasing hormone neurones in ovariectomized steroid-primed female rats.
Briski KP; Sylvester PW
J Neuroendocrinol; 1998 Oct; 10(10):769-76. PubMed ID: 9792328
[TBL] [Abstract][Full Text] [Related]
10. Intraventricular 2-deoxy-D-glucose induces Fos expression by hypothalamic vasopressin, but not oxytocin neurons.
Briski KP
Brain Res Bull; 2000 Feb; 51(3):275-80. PubMed ID: 10718520
[TBL] [Abstract][Full Text] [Related]
11. Glucoprivic induction of Fos immunoreactivity in hypothalamic dopaminergic neurons.
Briski KP
Neuroreport; 1998 Jan; 9(2):289-95. PubMed ID: 9507971
[TBL] [Abstract][Full Text] [Related]
12. Central opioid receptors mediate glucoprivic inhibition of pituitary LH secretion.
Briski KP
Am J Physiol; 1997 Apr; 272(4 Pt 1):E517-22. PubMed ID: 9142869
[TBL] [Abstract][Full Text] [Related]
13. Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus.
Greco MA; Fuller PM; Jhou TC; Martin-Schild S; Zadina JE; Hu Z; Shiromani P; Lu J
Brain Res; 2008 Dec; 1245():96-107. PubMed ID: 18840417
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions.
Ragnauth A; Ruegg H; Bodnar RJ
Brain Res; 1997 Aug; 767(1):8-16. PubMed ID: 9365010
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fos-like proteins in the preoptic area and hypothalamus of the rat brain following intracerebral or peripheral administration of colchicine.
Gillen E; Briski KP
Neurochem Res; 1997 May; 22(5):549-54. PubMed ID: 9131632
[TBL] [Abstract][Full Text] [Related]
16. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions.
Bodnar RJ; Glass MJ; Ragnauth A; Cooper ML
Brain Res; 1995 Nov; 700(1-2):205-12. PubMed ID: 8624711
[TBL] [Abstract][Full Text] [Related]
17. Septopreoptic mu opioid receptor mediation of hindbrain glucoprivic inhibition of reproductive neuroendocrine function in the female rat.
Singh SR; Briski KP
Endocrinology; 2004 Nov; 145(11):5322-31. PubMed ID: 15308614
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic orexin-A-immunpositive neurons express Fos in response to central glucopenia.
Briski KP; Sylvester PW
Neuroreport; 2001 Mar; 12(3):531-4. PubMed ID: 11234758
[TBL] [Abstract][Full Text] [Related]
19. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions.
Arjune D; Standifer KM; Pasternak GW; Bodnar RJ
Brain Res; 1990 Dec; 535(1):101-9. PubMed ID: 1963340
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of mu and kappa opiate receptor subtypes.
Callahan P; Baumann MH; Rabii J
J Neuroendocrinol; 1996 Oct; 8(10):771-6. PubMed ID: 8910807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
